---
title: "Insulet Corp. Stock Underperforms Friday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298770965.md"
description: "Insulet Corp. (PODD) shares fell 2.02% to $131.96 on Friday, underperforming the broader market as the S&P 500 and Dow Jones rose. This marks the stock's fifth consecutive day of losses, with the price now 62.82% below its 52-week high of $354.88. Trading volume reached 1.7 million, exceeding the 50-day average. Compared to competitors like Eli Lilly, DexCom, and Johnson & Johnson, Insulet also lagged in performance."
datetime: "2026-09-11T21:17:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298770965.md)
  - [en](https://longbridge.com/en/news/298770965.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298770965.md)
generator: "portal-rs"
---

# Insulet Corp. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) slid 2.02% to $131.96 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.86% to 7,656.98 and the Dow Jones Industrial Average rising 0.98% to 52,573.29.

This was the stock's fifth consecutive day of losses.

Insulet Corp. closed 62.82% short of its 52-week high of $354.88, which the company achieved on November 20th.

The stock underperformed when compared to some of its competitors Friday, as Eli Lilly & Co. (LLY) fell 0.65% to $1,115.70, DexCom Inc. (DXCM) fell 1.75% to $83.03, and Johnson & Johnson (JNJ) fell 0.29% to $265.58.

Trading volume (1.7 M) eclipsed its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-11-26 1717ET

### Related Stocks

- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Insulet Reprices $475 Million Term Loans, Expands Revolver to $750 Million in Credit Amendment](https://longbridge.com/en/news/299685094.md)
- [Insulet replaces USD 475 million term loans with lower-margin facility under amended credit agreement with Morgan Stanley agent](https://longbridge.com/en/news/299684116.md)
- [ANALYSIS-Big to get bigger: India's UPI fee shift to entrench dominant incumbents](https://longbridge.com/en/news/299727281.md)
- [Tesla Roadster Speculation Grows After FAA Sets 10,000-Foot Airspace Restriction](https://longbridge.com/en/news/299677194.md)
- [Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares jump](https://longbridge.com/en/news/299757599.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**